-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Boston Scientific, Lowers Price Target to $57

Benzinga·07/08/2026 10:25:34
Listen to the news
Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $77 to $57.